Fatigue in patients with metastatic breast cancer undergoing single-agent taxane-based chemotherapy: a real-world data global network.

Alessandra FabiElizabeth Marie GavioliRenuka WakadeMaria C SperaSantiago MiracleNeus ValvenyElizabeth ButlerMaria DePizzolPier Adelchi RuffiniMarcello Allegretti

Published in: Therapeutic advances in medical oncology (2024)

At least one in four patients with MBC undergoing taxane-based treatment will experience fatigue. This highlights the importance of validating screening tools to identify CRF, which is necessary to advance clinical trials aimed at investigating treatment strategies to improve patient-centered outcomes for fatigue.

Keyphrases

metastatic breast cancer
sleep quality
clinical trial
big data
electronic health record
randomized controlled trial
locally advanced
machine learning
physical activity
artificial intelligence
phase ii